Literature DB >> 9346680

Destruction of Kupffer cells increases survival and reduces graft injury after transplantation of fatty livers from ethanol-treated rats.

Z Zhong1, H Connor, R P Mason, W Qu, R F Stachlewitz, W Gao, J J Lemasters, R G Thurman.   

Abstract

This study investigated the role of Kupffer cells on survival and graft injury in transplanted fatty livers from rats treated acutely with ethanol. Donor rats were given ethanol (5 g/kg, by mouth) 20 hours before explantation, and liver grafts were preserved in University of Wisconsin cold storage solution for 24 to 42 hours prior to implantation. Blood samples were taken from the inferior vena cava for 3 hours after implantation. During this time, serum aspartate transaminase levels increased gradually from 122 U/L to 597 U/L in control rats, while ethanol treatment elevated values to 2,278 U/L. Gadolinium chloride (20 mg/kg, given intravenously to recipients 24 hours before explantation), a selective inactivator of Kupffer cells, minimized the increase in aspartate transaminase levels significantly. After implantation of grafts cold-stored for 42 hours, survival rates were 88% in control rats but only 33% in ethanol-treated rats. Gadolinium chloride improved survival nearly to control values. Ethanol nearly doubled white blood cell adhesion, an effect also largely blocked by gadolinium chloride. Further, alpha-(4-pyridyl 1-oxid)-N-tert-butylnitrone radical adducts detected in the bile were increased twofold by ethanol treatment. This effect was also reversed by gadolinium chloride. Taken together, these data indicate that survival is poorer and graft injury is greater in fatty livers from ethanol-treated rats. Inactivation of Kupffer cells minimized graft damage, most likely by improving hepatic microcirculation and diminishing lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9346680     DOI: 10.1002/lt.500020509

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  7 in total

1.  8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

2.  Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; Venkat K Ramshesh; Tom P Theruvath; Kenneth D Chavin; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

3.  Acute alcohol intoxication reduces mortality, inflammatory responses and hepatic injury after haemorrhage and resuscitation in vivo.

Authors:  B Relja; C Höhn; F Bormann; K Seyboth; D Henrich; I Marzi; M Lehnert
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Authors:  T S Dulkanchainun; J A Goss; D K Imagawa; G D Shaw; D M Anselmo; F Kaldas; T Wang; D Zhao; A A Busuttil; H Kato; N G Murray; J W Kupiec-Weglinski; R W Busuttil
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

5.  Icam-1 upregulation in ethanol-induced Fatty murine livers promotes injury and sinusoidal leukocyte adherence after transplantation.

Authors:  Tom P Theruvath; Venkat K Ramshesh; Zhi Zhong; Robert T Currin; Thomas Karrasch; John J Lemasters
Journal:  HPB Surg       Date:  2012-06-18

6.  Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.

Authors:  Qinlong Liu; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

7.  The impact of sterile inflammation in acute liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  J Clin Transl Res       Date:  2017-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.